Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Pharma’s path to Net Zero

Posted on May 3rd, 2022 by in Pharma R&D

Pharma is seldom top of mind when thinking about the most polluting industries, but pharmaceutical industry operations are in fact responsible for a significant portion of the world’s greenhouse gas emissions – even rivaling industries that are far more associated with contributing to the problem. 

(more…)

Harris Poll Finds Large Boost in Pharma Industry Reputation

Posted on March 15th, 2021 by in Pharma R&D

As the COVID-19 vaccine roll-out gains in intensity, it has become common to hear people toss out the names of pharmaceutical companies like Pfizer, Moderna and AstraZeneca with the same ease that they refer to their favorite brands of ketchup or peanut butter. This isn’t typical. While direct-to-consumer advertising has perhaps increased some awareness of drug makers, the pandemic has made pharma R&D a subject of public interest in an unprecedented fashion.

(more…)

Pharma Industry Conferences Have Gone Online – Will They Stay There?

Posted on December 3rd, 2020 by in Pharma R&D

Back in 2014, writer Nick de Cent posed the question Is it time for the conference to go virtual? He interviewed digital healthcare consultant Len Starnes, who argued that bringing pharma and healthcare conferences online could be beneficial in many ways, most notably in expanding participation. Six years later, and COVID-19 forced the issue, prompting many conferences to go fully virtual.

(more…)

Treating Pharma Data as an Asset: moving from an application centric to an information-centric organization – presented by Dr. Martin Romacker, Roche

Posted on July 14th, 2020 by in Pharma R&D

Pharma knows there is a need for clean, reusable, FAIR data to fuel effective machine learning-driven R&D – but driving effective information and knowledge management is a long process, needing a step change where individuals learn their roles in data stewardship and reduce them to practice in a way that doesn’t constrain or impede their research activities.

(more…)

  1. 1
  2. 2
  3. 3
  4. 12